TY  - JOUR
AU  - Manso, Luis
AU  - Sanchez-Muñoz, Alfonso
AU  - Calvo, Isabel
AU  - Izarzugaza, Yann
AU  - Plata, Jessica
AU  - Rodriguez, Cesar
PY  - 2018
DO  - 10.1159/000488794
SN  - 1661-3791
UR  - http://hdl.handle.net/10668/13080
T2  - Breast care (Basel, Switzerland)
AB  - The optimal sequence of anti-human epidermal growth factor receptor 2 (HER2) therapies in metastatic breast cancer (MBC) is still undetermined. Physicians must therefore make decisions based on clinical trials and their own experience for the best...
LA  - en
KW  - Antineoplastic agents
KW  - HER2-positive
KW  - Loss of chance
KW  - Metastatic breast cancer
KW  - Oncologists
KW  - Trastuzumab emtansine
TI  - Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer.
TY  - research article
VL  - 13
ER  -